IV Ibuprofen Market Size, Analysis & Forecast 2015 - 2022

1. World Intravenous (IV) Ibuprofen Market Opportunities and Forecasts, 2015 – 2022 Published Date: April 2016

2. Introduction of Intravenous IbuprofonMarket Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness. The intravenous (IV) route for ibuprofen administration has a faster onset of action as compared to the other routes. IV ibuprofen is preferred for the management of post-operative and acute pain. The demand for ibuprofen has increased due to the side effects of opioid analgesics such as respiratory depression, allergic reactions, sedation, and gastrointestinal events. The market for IV ibuprofen for pain management is in its nascent stage. The world IV ibuprofen market was valued at $3.6 million in 2015, and is projected to reach $14.2 million by 2022, registering a CAGR of 20% during the forecast period. Advantages associated with IV ibuprofen such as rapid result and targeted drug delivery have resulted in the growth of this market. In 2015, FDA approved IV ibuprofen for pediatric use, due to which the market is expected to register a significant growth during the forecast period. Other factors that affect the market growth significantly include increasing incidence of cancer, cardiovascular ailments, pain, headache, toothache, back pain, arthritis, trauma, and shifting trend towards the use of non-opioids drugs. Factors that would hamper the market growth include side effects associated with IV ibuprofen and lengthy approval process. Read more details at: https://www.alliedmarketresearch.com/intravenous-ibuprofen-market

3. Introduction Scopeof theReport KeyBenefits KeyAudiences

4. KeyBenefits IntroductiontoSmart Syringes Market Synthetic biology is a novel area of research that is the amalgamation of multiple disciplines such as molecular biology, biotechnology, biophysics and genetic engineering among others. There are chiefly two approaches used in synthetic biology namely, top down approach and bottom up approach. Top-down approach involves the re-design and fabrication of existing biological systems for producing synthetic products. Bottom-up approach involves designing and construction of de novo biological systems or devices that do not exist in nature. World synthetic biology market was valued at $ 5,245.7 million in 2015, growing at a CAGR of 23% during the forecast period. Assistance from government and private organizations, rising number of synthetic biology research entities and declining cost of DNA sequencing & synthesizing are the major factors driving the market growth. On the contrary, bio-safety & bio-security issues, would hinder the market growth. The issues related to the misuse of synthetic biology or possibilities of accidental release of pathogens into free atmosphere would remain as a key challenge worldwide. However, rising demand for bio-fuels, growing awareness in emerging economies and rising R&D investments for synthetic drugs and vaccines would offer lucrative opportunities in the market • This report provides an extensive analysis of the current and emerging trends and dynamics in the world IV Ibuprofen market. • The world IV Ibuprofen market is analyzed based on countries such as the U.S., Australia, Canada and South Korea. • The study evaluating competitive landscape has been taken into account to understand the competitive environment across the countries considered. • This report provides detailed quantitative analysis of the current market and estimations from 2015 to 2022, which assists to identify the prevailing opportunities. • Exhaustive analysis of the world IV Ibuprofen market by indication describes the types of indications that will gain prominence in future.

5. Table ofContents: Introduction ExecutiveSummary MarketOverview 4. World Intravenous Ibuprofen market, By Age Group, 2015-2022 5. World Intravenous Ibuprofen Market, By Indication, 2015-2022 6. World Intravenous Ibuprofen Market, By Country, 2015-2022 Company Profiles Enquiry about report at: https://www.alliedmarketresearch.com/purchase-enquiry/1387

6. World Intravenous Ibuprofen – Market By Segments

7. IntroductiontoSmart Syringes Market Synthetic biology is a novel area of research that is the amalgamation of multiple disciplines such as molecular biology, biotechnology, biophysics and genetic engineering among others. There are chiefly two approaches used in synthetic biology namely, top down approach and bottom up approach. Top-down approach involves the re-design and fabrication of existing biological systems for producing synthetic products. Bottom-up approach involves designing and construction of de novo biological systems or devices that do not exist in nature. World synthetic biology market was valued at $ 5,245.7 million in 2015, growing at a CAGR of 23% during the forecast period. Assistance from government and private organizations, rising number of synthetic biology research entities and declining cost of DNA sequencing & synthesizing are the major factors driving the market growth. On the contrary, bio-safety & bio-security issues, would hinder the market growth. The issues related to the misuse of synthetic biology or possibilities of accidental release of pathogens into free atmosphere would remain as a key challenge worldwide. However, rising demand for bio-fuels, growing awareness in emerging economies and rising R&D investments for synthetic drugs and vaccines would offer lucrative opportunities in the market Intravenous Ibuprofen Market Key Pain/Inflammatory By Indications Fever

8. IntroductiontoSmart Syringes Market Synthetic biology is a novel area of research that is the amalgamation of multiple disciplines such as molecular biology, biotechnology, biophysics and genetic engineering among others. There are chiefly two approaches used in synthetic biology namely, top down approach and bottom up approach. Top-down approach involves the re-design and fabrication of existing biological systems for producing synthetic products. Bottom-up approach involves designing and construction of de novo biological systems or devices that do not exist in nature. World synthetic biology market was valued at $ 5,245.7 million in 2015, growing at a CAGR of 23% during the forecast period. Assistance from government and private organizations, rising number of synthetic biology research entities and declining cost of DNA sequencing & synthesizing are the major factors driving the market growth. On the contrary, bio-safety & bio-security issues, would hinder the market growth. The issues related to the misuse of synthetic biology or possibilities of accidental release of pathogens into free atmosphere would remain as a key challenge worldwide. However, rising demand for bio-fuels, growing awareness in emerging economies and rising R&D investments for synthetic drugs and vaccines would offer lucrative opportunities in the market Intravenous Ibuprofen Market Key Pediatrics By Age Groups Adults

9. Company Profiles Cumberland Pharmaceuticals Inc. Alveda Pharmaceuticals, Inc. CSL Limited, Sandor MedicaidsPvt Ltd. PT. SohoIndustriPharmasi Germin MED, Grifols S.A. Harbin Gloria Pharmaceuticals Co., Ltd. Al Nabeel International Ltd. LaboratoriosValmorca, C.A.

10. Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/intravenous-ibuprofen-market Follow Us On